Aiming to avoid damage to neurocognitive areas of the brain during cranial radiation

Nov 03, 2009

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.

The goal is to spare these areas, which are responsible for short-term memory, as well as emotions, motivation, and a range of executive functions, such as planning and decision-making.

Cranial radiation is used to destroy tumors that have spread to the brain, which happens in 20 to 25 percent of all cancer patients. It is also used prophylactically to prevent the development of overt intracranial metastases in patients diagnosed with small-cell lung carcinoma.

But there is a downside to the treatment. Because the hippocampus and the limbic area are irradiated along with the rest of the brain, the treatment often causes memory lapses, difficulty with executive planning, and poor fine motor control. The consequences can be devastating for patients, whose quality of life is deeply affected.

In a review of records for 107 patients with 700 lesions, the team of radiation oncologists at Rush found that metastases had occurred in the hippocampus in only 0.8 percent of the cases, and in the limbic circuit in fewer than 3 percent of cases.

That finding emboldened them to determine whether it might be possible to deliver cranial radiation to the brain, but not to these particular areas - eliminating metastases or potential metastases with radiation but sparing the hippocampus and the limbic areas, where metastases were unlikely to occur.

In their feasibility study, the researchers were able to show that the hippocampus and limbic circuit can be largely spared using advanced equipment that targets the radiation to specific areas.

Their results are being presented in a poster session at the annual meeting of the American Society for Radiation Oncology, which is being held November 1-5 in Chicago.

"We have shown that it is possible to reduce the dose of radiation to this area, while treating the rest of the brain, where the is located, at full dose," said Dr. Arnold Herskovic, principal investigator of the study.

The feasibility study was done using a TomoTherapy Hi-Art System, which enables the treatment of tumors with image-guided therapy.

The researchers expect to start a clinical trial of the new procedure soon to determine whether in fact it can both prevent or treat brain and minimize long-term neurocognitive consequences.

Source: Rush University Medical Center (news : web)

Explore further: Cancer researchers identify irreversible inhibitor for KRAS gene mutation

add to favorites email to friend print save as pdf

Related Stories

Drug combination shrinks breast cancer metastases in brain

Dec 16, 2007

A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber ...

Brain irradiation in lung cancer

Jun 03, 2009

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment ...

Recommended for you

Cancer: Tumors absorb sugar for mobility

5 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

Early hormone therapy may be safe for women's hearts

14 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

15 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

User comments : 0